Search Results 101-110 of 13851 for Assay
... assay obtained at baseline. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
The purpose of the study is to optimize and validate the performance of the Senseera liquid biopsy cfChIP-seq assay for the detection of Acute Cellular ...
The purpose of this study is to compare the ability of Plateletworks Arachidonic Acid (AA) and ADP tests, and TEG 6S AA and ADP percent activity/inhibition ...
Our hypothesis is that in CMV D+/R- solid organ transplant recipients, the development of immunity as measured by a positive QuantiFERON CMV assay will predict ...
About this study. The purpose of this study is to monitor and validate the performance and stability of the BRAHMS Chromogranin A (CgA) II KRYPTOR Assay in ...
... assay for the detection of mutations associated with uveal melanoma. The performance characteristics of the ddPCR assay for the detection of ctDNA mutation ...
... assay for predicting response to treatment on an individualized basis for Mayo Clinic cancer patients. Participation eligibility. Participant eligibility ...
... assay used. Therefore, if analog insulin is present in the circulation, the immunoassay can give a result anywhere along a spectrum of undetectable to ...
Research and development. Upon request, the Targeted Biomarker Core can test most assays or kits available on its current platforms. For novel assay development ...
We propose to develop tissue-based biomarker assays for the diagnosis and therapeutic prognosis for inflammatory skin diseases. Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.